Bryn Mawr Trust CO Eli Lilly & CO Transaction History

Bryn Mawr Trust CO

$2.54 Billion
Q1 2024

A detailed history of Bryn Mawr Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Bryn Mawr Trust CO holds 17,636 shares of LLY stock, worth $15.1 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

17,636

Previous 18,988 7.12%

Holding current value

$15.1 Million

Previous $10.2 Million 34.52%

% of portfolio

0.54%

Previous 0.46%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $800,654 - $1.07 Million	-1,352 Reduced 7.12%	17,636 $13.7 Million
Q3 2023 Nov 15, 2023	SELL	$434.7 - $599.3 $103,458 - $142,633	-238 Reduced 1.24%	18,988 $10.2 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $251,129 - $335,789	-716 Reduced 3.59%	19,226 $9.02 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $364,679 - $428,298	-1,174 Reduced 5.56%	19,942 $6.85 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $168,170 - $195,952	-523 Reduced 2.42%	21,116 $7.73 Million

Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $40,914 - $46,626	-138 Reduced 0.63%	21,639 $7 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $765,950 - $899,337	-2,748 Reduced 11.2%	21,777 $7.06 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $97,161 - $120,747	-414 Reduced 1.66%	24,525 $7.02 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $35,976 - $44,646	-160 Reduced 0.64%	24,939 $6.89 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $263,260 - $323,979	-1,188 Reduced 4.52%	25,099 $5.8 Million
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $70,775 - $91,547	392 Added 1.51%	26,287 $6.03 Million
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $220,188 - $285,044	-1,340 Reduced 4.92%	25,895 $4.84 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $214,867 - $284,321	-1,647 Reduced 5.7%	27,235 $4.6 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $416,727 - $482,020	-2,850 Reduced 8.98%	28,882 $4.28 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $233,278 - $280,747	-1,710 Reduced 5.11%	31,732 $5.21 Million
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $206,551 - $255,652	-1,735 Reduced 4.93%	33,442 $4.64 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $16,572 - $20,526	-155 Reduced 0.44%	35,177 $4.62 Million
Q3 2019 Oct 24, 2019	SELL	$106.79 - $116.16 $179,513 - $195,264	-1,681 Reduced 4.54%	35,332 $3.95 Million
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $465,871 - $543,790	-4,205 Reduced 10.2%	37,013 $4.1 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $324,134 - $381,530	-2,912 Reduced 6.6%	41,218 $5.35 Million
Q4 2018 Aug 28, 2019	BUY	$105.9 - $118.64 $291,225 - $326,260	2,750 Added 6.65%	44,130 $5.11 Million
Q4 2018 Feb 15, 2019	SELL	$105.9 - $118.64 $184,901 - $207,145	-1,746 Reduced 4.05%	41,380 $4.79 Million
Q3 2018 Aug 28, 2019	BUY	$85.86 - $107.31 $236,115 - $295,102	2,750 Added 6.81%	43,126 $4.63 Million
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $262,989 - $328,690	-3,063 Reduced 7.05%	40,376 $4.33 Million
Q2 2018 Aug 28, 2019	BUY	$75.7 - $86.88 $208,175 - $238,920	2,750 Added 6.76%	43,439 $3.71 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $229,673 - $263,593	-3,034 Reduced 6.94%	40,689 $3.47 Million
Q1 2018 Aug 28, 2019	BUY	$74.21 - $87.6 $204,077 - $240,899	2,750 Added 6.71%	43,723 $3.38 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $217,064 - $256,229	-2,925 Reduced 6.66%	40,973 $3.17 Million
Q4 2017 Aug 28, 2019	BUY	$81.94 - $87.89 $225,335 - $241,697	2,750 Added 6.68%	43,898 $3.71 Million
Q4 2017 Feb 15, 2018	SELL	$81.94 - $87.89 $269,336 - $288,894	-3,287 Reduced 7.4%	41,148 $3.48 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $3.42 Million - $3.8 Million	44,435	44,435 $3.8 Million

Others Institutions Holding LLY

# of Institutions

3,747

Shares Held

737M

Call Options Held

7.09M

Put Options Held

7.22M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $815B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Account

Bryn Mawr Trust CO Eli Lilly & CO Transaction History